Global Human Milk Oligosaccharides (HMOs) Market By Type (2’FL, 3’FL, 3’SL, 6’SL), Product (Fucosyllactose, LNT & LNnT, Sialyllactose), Application (Infant Formula, Functional Food & Beverages, Food Supplements, Health Ingredients for Human and Animal, Others) Distribution Channel (Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, and Online Sales Channel) – Industry Trends and Forecast to 2029
Market Analysis and Size
Human Milk Oligosaccharides (HMOs) are beneficial to immunity, key players in the human milk oligosaccharides (HMO) market are developing new techniques to produce them , such as extracting HMO from cow milk, using expensive procedures (chemical or enzymatic synthesis), or using microbes. Market products containing human milk oligosaccharides (HMO) are expensive because a large amount of human milk is synthesized to produce a small HMO. As a result of continual research and development, synthesis and extraction procedures are improving.
Data Bridge Market Research analyses that the human milk oligosaccharides (HMOs) market was valued at USD 22.3 Million in 2021 is expected to reach the value of USD 109.51 Million by 2029, at a CAGR of 22.01% during the forecast period of 2022 to 2029. People's increasing awareness of gut health will be a factor in the human milk oligosaccharides market.
Market Definition
HMOs are prebiotics that is naturally found in a mother's breast milk. After fat and carbohydrates, they are the most abundant solid ingredient in breast milk. HMOs have been shown in studies to benefit the microbiome of breastfed babies.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (2’FL, 3’FL, 3’SL, 6’SL), Product Type (Fucosyllactose, LNT & LNnT, Sialyllactose), Application (Infant Formula, Functional Food & Beverages, Food Supplements, Health Ingredients for Human and Animal, Others), Distribution Channel (Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, and Online Sales Channel)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, France, Netherlands, U.K., Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
ZuChem Inc. (U.S), Elicityl SA (France), Jennewein Biotechnologie GmbH (Germany), Royal FrieslandCampina NV (Netherlands), BASF SE (Germany), Gnubiotics (Switzerland), DuPont Nutrition & Health (Denmark), Inbiose NV (Belgium), Glycom A/S (Denmark), Glycosyn LLC (U.S.)
|
|
Opportunities
|
|
Human Milk Oligosaccharides (HMOs) Market Dynamics
Drivers
- Rising demand for dietary supplements
Increasing demand for dietary supplements, improvement in metabolic activity by promoting bacterial growth, and an increase in the number of applications from pharmaceuticals, infant formulas, and medicinal foods are some of the factors that will drive the growth of the human milk oligosaccharides market
- Benefits in brain development and memory enhancement
It aids in brain development and memory enhancement, which will increase the number of opportunities for the human milk oligosaccharides market during the forecast period.
Opportunity
For a long time, HMOs have been used in infant formula and human milk. However, the compositions differ, and HMOs are not found in other foods. The approach to the market for new and novel Human Milk Oligosaccharides (HMOs) as a dietary supplement is to get GRAS self-affirmed for use in food and then utilise it as a dietary supplement. Such notices have been issued for 2'-O-fucosyllactose, 2'-fucosyllactose, and lacto-N-neotetraose.
Restraints
The lack of technology for large-scale production and stringent regulations and high development costs will stymie the growth of the human milk oligosaccharides market during the forecast period.
This human milk oligosaccharides (HMOs) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the human milk oligosaccharides (HMOs) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Human Milk Oligosaccharides (HMOs) Market
The COVID-19 epidemic, according to industry observers, has a beneficial impact on the market for Human Milk Oligosaccharides. When the lockdown was enacted, there was a surge in demand for HMOs due to panic buying for at-home use during the early stages of the epidemic. As a result of the belief that HMOs work as immunity boosters, HMO sales increased during the pandemic.
Recent Development
Over the years, prominent market participants have invested in R&D activities to innovate their product offerings. For example, Jennewein Biotechnologie GmbH, a functional sugars manufacturer based in Germany, collaborated with Yili.Com Inc., a dairy products manufacturer based in China, in February 2019 to research infant microbiome and human milk oligosaccharides. This strategy was designed to develop innovative, HMO-based infant formula for Chinese customers. Given the increasing market competition, such developments/strategies are likely to emerge during the forecast period.
Global Human Milk Oligosaccharides (HMOs) Market Scope
The human milk oligosaccharides (HMOs) market is segmented on the basis of type, product type, distribution channel an application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- 2’FL
- 3’FL
- 3’SL
- 6’SL
On the basis of type, the human milk oligosaccharides (HMOs) market is segmented into 2’FL, 3’FL, 3’SL, and 6’SL.
Product
- Fucosyllactose
- Lnt & LNnt
- Sialyllactose
Based on product type, the human milk oligosaccharides (HMOs) market is segmented into fucosyllactose, LNT & LNnT, and sialyllactose.
Application
- Infant formula
- Functional food & beverages
- Food supplements
- Health ingredients for human and animal
- Other
Based on the application, the human milk oligosaccharides (HMOs) market is segmented into infant formula, functional food & beverages, food supplements, health ingredients for human and animal, others.
Distribution channel
- Hypermarkets and supermarkets
- Drug store or pharmacy
- Mass merchandiser
- Departmental stores
- Mono-brand stores
- Specialty stores
- Online sales channel
Based on the distribution channel the human milk oligosaccharides (HMOs) market is segmented into hypermarkets and supermarkets, drug store or pharmacy, mass merchandiser, departmental stores, mono-brand stores, specialty stores, and online sales channel.
Human Milk Oligosaccharides (HMOs) Market Regional Analysis/Insights
The human milk oligosaccharides (HMOs) market is analyzed and market size insights and trends are provided by country, type, product type and application as referenced above.
The countries covered in the human milk oligosaccharides (HMOs) market report are U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe dominates the HMOs, with Germany likely to be a large country-level market contributing to the expansion of the European market. Because of increased health consciousness among consumers in the region, the Asia-Pacific market is expected to grow fastest during the forecast period.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Human Milk Oligosaccharides (HMOs) Market Share Analysis
The human milk oligosaccharides (HMOs) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to human milk oligosaccharides (HMOs) market.
Some of the major players operating in the human milk oligosaccharides (HMOs) market are:
- ZuChem Inc. (U.S)
- Elicityl SA (France)
- Jennewein Biotechnologie GmbH (Germany)
- Royal FrieslandCampina NV (Netherlands)
- BASF SE (Germany)
- Gnubiotics (Switzerland)
- DuPont Nutrition & Health (Denmark)
- Inbiose NV (Belgium)
- Glycom A/S (Denmark)
- Glycosyn LLC (U.S.)
SKU-